GSK and Shenzhen Neptunus create new alliance to develop and manufacture influenza vaccines in China

GSK today announced it has entered into a definitive agreement to form a new Joint Venture with Shenzhen Neptunus focused on developing and manufacturing influenza vaccines for the Chinese market.